Exozymes Inc. (EXOZ) stock
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$3.83−0.17 (-4.25%)
Close on Nov 13, 2026Market cap $35.55MP/E –Yield –
Exozymes enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Exozymes's enterprise value was $31.47M on Nov 11, 2026, against $128.01M a year earlier. Over the last 2 years it ranged from $31.47M to $131.70M, with a median of $78.55M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $31.47M | -63.5% |
| 2025 | Dec 31, 2025 | $86.32M | -16.1% |
| 2024 | Dec 31, 2024 | $102.93M | – |
See a number that looks wrong?